Recent Articles

Daily cup of coffee may prevent afib recurrence

Gene-editing therapy lowers harmful blood fats in early study

What is EMDR therapy, and who can it help?

GLP-1 drugs versus bariatric surgery for treating obesity

Trying to lose weight? Be careful not to lose muscle

Two dumbbells, three exercises, and 10 minutes

Easing the emotional burden of IBS

Modify your push-ups to meet your fitness level

What is long QT syndrome?

Stroke survivors may benefit from very low LDL levels

Mark Benson, MD, PhD

Contributor

Mark D. Benson, M.D., Ph.D. is the Director of Preventive Cardiology at Beth Israel Deaconess Medical Center (BIDMC). He is also a basic and translational researcher in the field.

Dr. Benson received his B.A. in biological sciences from Columbia University and his M.D. and Ph.D. in pharmacology from the University of Michigan. He completed his residency training in internal medicine at the University of Michigan, his fellowship training in cardiology at Brigham and Women’s Hospital, and his post-doctoral training in multi-omics research at BIDMC.

Dr. Benson is a principal investigator at the CardioVascular Institute at BIDMC. His laboratory’s interests are focused on applying emerging metabolomics, proteomics, and genomics technologies to detect signatures of small molecules in blood that may be used to predict an individual’s future risk of developing cardiovascular disease. The ultimate goal of this research is to identify novel biomarkers and pharmacological targets that may improve preventive cardiovascular disease therapy.

Posts by Mark Benson, MD, PhD